Sofinnova Investments’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-89,919
Closed -$1.22M 60
2018
Q3
$1.22M Buy
+89,919
New +$1.22M 0.11% 56